Objective. Microsomal prostaglandin E synthase 1 (mPGES-1) is the final enzyme of the cascade that produces prostaglandin E 2 (PGE 2 ), a key actor in arthritis. To study mPGES-1 synthesis in human cartilage and its regulation by interleukin-1 (IL-1), we used human cartilage and an immortalized human chondrocyte cell line. Furthermore, we investigated the signaling pathways involved in mPGES-1 expression.Methods. We used real-time quantitative reverse transcription-polymerase chain reaction, Northern blotting, and Western blotting to measure mPGES-1 messenger RNA (mRNA) and protein expression in human chondrocytes. PGE 2 production was measured by enzyme-linked immunosorbent assay.Results. Cartilage specimens from osteoarthritis (OA) patients contained far greater amounts of mPGES-1 and cyclooxygenase 2 (COX-2) mRNA than did normal cartilage. Incubation with IL-1 markedly increased mPGES-1 mRNA and protein in a dosedependent and time-dependent manner, in parallel with an increase in PGE 2 levels. Both PD98059, an ERK pathway inhibitor, and SB203580, a p38␣/ MAPK inhibitor, abolished the increases in mPGES-1 mRNA and protein in response to IL-1. The specific p38␣ MAPK inhibitor SC906 suppressed IL-1-induced COX-2 expression but not IL-1-induced mPGES-1 expression, suggesting preferential involvement of p38 MAPK in IL-1-induced mPGES-1 expression.Conclusion. This study is the first to show that mPGES-1 is stimulated in human chondrocytes by the proinflammatory cytokine IL-1 via activation of both ERK-1/2 and p38 MAPK in an isoform-specific manner. We postulate that mPGES-1 may be a novel target for OA therapy.Prostaglandin E 2 (PGE 2 ) plays an important role in cartilage metabolism. Its many effects on chondrocytes (for review, see ref. 1) include enhanced production of matrix metalloproteinase 3 (2), modulation of proteoglycan and collagen synthesis (2,3), and stimulation of chondrocyte apoptosis (4,5). The synovial fluid of patients with osteoarthritis (OA) and rheumatoid arthritis contains high concentrations of PGE 2 (4), and cartilage and chondrocytes from OA patients spontaneously release more PGE 2 than does normal cartilage (2,6,7). These results suggest that PGE 2 may be actively involved in cartilage breakdown in OA patients. PGE 2 is synthesized by the isoenzymes cyclooxygenase 1 (COX-1) and COX-2, both of which act on arachidonic acid to form the prostaglandin endoperoxide H 2 (PGH 2 ). The prostanoid synthase prostaglandin E synthase (PGES) produces PGE 2 from PGH 2 . Three